Study 200977: Albiglutide + Insulin Glargine Versus Insulin Lispro + Insulin Glargine in the Treatment of Subjects With Type 2 Diabetes Mellitus: The Switch Study
Phase of Trial: Phase III
Latest Information Update: 20 Nov 2017
At a glance
- Drugs Albiglutide (Primary) ; Insulin glargine; Insulin lispro
- Indications Type 2 diabetes mellitus
- Focus Registrational; Therapeutic Use
- Acronyms The Switch Study
- Sponsors GlaxoSmithKline
- 11 Aug 2017 Status changed from active, no longer recruiting to completed.
- 11 Aug 2017 This study has been completed in Spain.
- 10 Jun 2017 Biomarkers information updated